Rua Bioscience (RUA.NZ) Stock Price

Rua Bioscience Price

CLOSED
0.03
​
Market closed

Over the last 3 years Rua Bioscience grew revenue by 296.7% annually, reaching 1.51 M NZD. For Rua Bioscience, the net margin of -228.7% is up versus -35,686.0% a few years ago.

Rua Bioscience stock price

Access this data via the Eulerpool API

Rua Bioscience business model & stock analysis

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm is engaged in the business of research and development, and pharmaceutical distribution and marketing. The firm is focused on breeding, cultivating, manufacturing, and supplying medicinal cannabis. The firm operates through one segment: research and development and the sale of pharmaceutical products in Germany and New Zealand. The firm also operates a full research laboratory in Gisborne, which enables cannabinoid testing, microscopic analysis, moisture analysis, sample preparation and extraction, solvent removal, viscosity measurements, and impurity testing.

Frequently asked questions about Rua Bioscience

Converted at the current exchange rate, the Rua Bioscience share trades at 0.01 EUR (0.03 NZD).

The revenue cannot currently be calculated for Rua Bioscience.

The profit cannot currently be calculated for Rua Bioscience.

The P/E ratio cannot be calculated for Rua Bioscience at the moment.

The P/S cannot be calculated for Rua Bioscience currently.

The Eulerpool Quality Score for Rua Bioscience is 3/10.

The ISIN of Rua Bioscience is NZRUAE0004S1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Rua Bioscience is RUA.NZ. The ticker symbol is used to trade Rua Bioscience shares on the stock exchange.

Fair ValueTerminal
0.02 NZD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ruabio.com
Country
New Zealand
Currency
NZD
Initial public offering
Oct 22, 2020
ISIN
NZRUAE0004S1
Cusip
Q8161A107
Market capitalization
8.79 M NZDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.80
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-60.68 %
Last updated Oct 12, 2026, 7:03 AM

Rua Bioscience Peer Group

Rua Bioscience FIGI

RUA:NZ · BBG00XM9SLF0